SynCore Biotechnology Co.,Ltd reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 2.92 million compared to TWD 1.28 million a year ago. Net loss was TWD 33.97 million compared to TWD 88.24 million a year ago. Basic loss per share from continuing operations was TWD 1.1229 compared to TWD 2.8821 a year ago.
For the six months, sales was TWD 6.28 million compared to TWD 2.59 million a year ago. Net loss was TWD 76.34 million compared to TWD 159.81 million a year ago. Basic loss per share from continuing operations was TWD 2.4704 compared to TWD 5.3151 a year ago.